Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Insoo Bae

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
DNA Repair|October 8, 2011
Effects of solvents on in vitro potencies of platinum compoundsYong Weon Yi, Insoo Bae
Cancers|April 8, 2014
BRCA1 and Oxidative StressYong Weon Yi, Hyo Jin Kang, Insoo Bae
Journal of Cellular Biochemistry|November 2, 2007
Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of ironSung-Soo Park, Insoo Bae, Yong J Lee
The Journal of Biological Chemistry|April 30, 2010
CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasome-mediated degradationHyo Jin Kang, Young Bin Hong, Hee Jeong Kim, et al.
Toxicology Letters|December 24, 2011
Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cellsHyo Jin Kang, Young Bin Hong, Hee Jeong Kim, et al.
Oncology Reports|October 14, 2011
ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabineHong-Quan Duong, Hee Jeong Kim, Hyo Jin Kang, et al.
Pancreas|March 15, 2012
Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancerYoung Bin Hong, Jung Soon Kim, Yong Weon Yi, et al.
Anticancer Research|March 9, 2012
Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabineYeon Jeong Kim, Jae Seok Hwang, Young Bin Hong, et al.
Pancreas|June 15, 2012
Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancerYeon Jeong Kim, Young Bin Hong, Chi Heum Cho, et al.
International Journal of Oncology|October 19, 2012
BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cellsHong-Quan Duong, Jae Seok Hwang, Hee Jeong Kim, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
DNA Repair|October 8, 2011
Effects of solvents on in vitro potencies of platinum compoundsYong Weon Yi, Insoo Bae
Cancers|April 8, 2014
BRCA1 and Oxidative StressYong Weon Yi, Hyo Jin Kang, Insoo Bae
Journal of Cellular Biochemistry|November 2, 2007
Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of ironSung-Soo Park, Insoo Bae, Yong J Lee
The Journal of Biological Chemistry|April 30, 2010
CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasome-mediated degradationHyo Jin Kang, Young Bin Hong, Hee Jeong Kim, et al.
Toxicology Letters|December 24, 2011
Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cellsHyo Jin Kang, Young Bin Hong, Hee Jeong Kim, et al.
Oncology Reports|October 14, 2011
ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabineHong-Quan Duong, Hee Jeong Kim, Hyo Jin Kang, et al.
Pancreas|March 15, 2012
Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancerYoung Bin Hong, Jung Soon Kim, Yong Weon Yi, et al.
Anticancer Research|March 9, 2012
Transforming growth factor beta receptor I inhibitor sensitizes drug-resistant pancreatic cancer cells to gemcitabineYeon Jeong Kim, Jae Seok Hwang, Young Bin Hong, et al.
Pancreas|June 15, 2012
Exploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancerYeon Jeong Kim, Young Bin Hong, Chi Heum Cho, et al.
International Journal of Oncology|October 19, 2012
BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cellsHong-Quan Duong, Jae Seok Hwang, Hee Jeong Kim, et al.
Pageof 5